Analysts expect over 2020 rising revenue Carl Zeiss Meditec

On Monday Carl Zeiss Meditec will publish its past quarters results. Over the current book year the total revenue will be 1,51 billion euros (consensus estimates). This is slightly more than 2018's revenue of 1,46 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2020

The analysts expect for 2020 a net profit of 172 million euros. The majority of the analysts expects for this year a profit per share of 1,92 euros. So the price/earnings-ratio equals 50.

For this year most of the analysts expect a dividend of 0,7 cents per share. The dividend yield is then 0,73 percent. The average dividend yield of the pharmaceutical companies equals an attractive 6,35 percent.

Latest estimates around 122 euros

The latest 3 recommendations for the pharmaceutical company were provided by Nord Landesbank, Independent Research and Deutsche Bank.

Carl Zeiss Meditec's market capitalization is based on the number of outstanding shares around 8,59 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite volatile. Since last May the stock is 12 percent higher. This year the stock price moved between 68 and 122 euro. Since 2008 the stock price is almost 747 percent higher.

Historical stock prices Carl Zeiss Meditec period 2007-2020

Click here for dividend . At 12.28 the stock trades 0,16 percent higher at 96 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.